PET imaging of CXCR4 using copper-64 labeled peptide antagonist. - Wikidata - wikimedia - TriplyDB

PET imaging of CXCR4 using copper-64 labeled peptide antagonist.

PET imaging of CXCR4 using copper-64 labeled peptide antagonist.

http://www.wikidata.org/entity/Q34895626

about

Sequential administration of the high affinity CXCR4 antagonist BKT140 promotes megakaryopoiesis and platelet production.Chelator-free (64)Cu-integrated gold nanomaterials for positron emission tomography imaging guided photothermal cancer therapy.Image guided biodistribution and pharmacokinetic studies of theranostics.Intrinsically radioactive [64Cu]CuInS/ZnS quantum dots for PET and optical imaging: improved radiochemical stability and controllable Cerenkov luminescence.The intricate role of CXCR4 in cancer.Multimodal bacteriochlorophyll theranostic agent.Transforming a Targeted Porphyrin Theranostic Agent into a PET Imaging Probe for Cancer.Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging Prospective Study of (68)Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and First Application in Glioma Patients.Improvement of CXCR4 tracer specificity for PET imaging Development of individualized anti-metastasis strategies by engineering nanomedicines Stroma targeting nuclear imaging and radiopharmaceuticals.CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential.Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Multimodality imaging of CXCR4 in cancer: current status towards clinical translation.Comparison of (18)F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression.Peptide-based imaging agents for cancer detection.Al[18F]NOTA-T140 Peptide for Noninvasive Visualization of CXCR4 Expression.CXCR4-based imaging agents.Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4).Differential Expression of Chemokine Receptors and their Roles in Cancer Imaging.Imaging agents for the chemokine receptor 4 (CXCR4).Molecular imaging of chemokine receptor CXCR4.Cancer biomarker discovery: current status and future perspectives.Molecular imaging probes derived from natural peptides.Meeting the challenges of PET-based molecular imaging in cancer.The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression.Prospective of 68Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation.

P2860

Q33409463-41E50848-BC39-4510-813F-C51A399ABD52 Q34104295-947398EC-1E27-42C9-89FA-46D20A0D99DE Q34506838-44FA61DA-5A61-49FB-841C-5CAD9BDA2180 Q35027192-E0698324-53E8-4556-9D96-C0B2C1315D61 Q35067624-4C2233C6-D40F-4592-9921-0687512F96A0 Q35224467-2DF82867-0BAF-4045-A18C-506D29B78F74 Q35224469-697F3A19-DEB8-40A6-B87E-1DE79C886126 Q35227508-555BF170-DC9E-4FB2-8AD1-3F7BF2285730 Q35633357-C897119C-F5D9-49F6-8069-9976DF637690 Q35675254-48DE0BAE-70C5-4CAB-A31F-F09873D1B854 Q35967474-0E92A0CC-E7F8-4B3A-8EEF-A465F1A56AD5 Q35999606-D99DACBF-53A1-4116-A4B9-F6087F7712EE Q36583985-1B2161E4-47C9-495B-AF68-1917C0677958 Q37136682-281720A3-83AE-4266-8667-FF19ADB13CDA Q37236103-8EBAB641-FBEA-4E87-A951-1DFFCCC019F5 Q37337280-DFF60C2B-BE8B-486C-B994-D631EB3D2794 Q37393337-5D718617-637C-497F-AE9D-C659DD3E8D35 Q37585965-8240B994-A626-4026-AC95-9EF8E7D5F311 Q37592059-13B555C4-23CF-40AE-90A6-2F18FC952996 Q37951878-0725915E-6300-4582-A5B1-D27C2C7D1192 Q38003847-D4024685-9506-46A3-A75F-8E34BB5F6094 Q38015856-3172422D-60DF-4319-A120-AEA1D091F287 Q38022430-5ED9B5C0-EED4-4D1B-91F9-47E8A19C2580 Q38079238-FBEF6589-98E8-4D8E-9257-004FC386A883 Q38187679-413F3054-E3BD-48A1-8109-3C83BDC4BB49 Q38748846-D1CB8D5C-7CF0-4F49-AFBA-C58D17285043 Q39345390-A20DD043-C827-4188-9C02-66604840E862 Q45865484-404B6A7E-F244-4C27-9F85-89D5A9329EC6 Q54257268-D0DCC98A-3EC7-4080-9499-0B64087E65E3

P2860

PET imaging of CXCR4 using copper-64 labeled peptide antagonist.

http://www.wikidata.org/entity/Q34895626

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

PET imaging of CXCR4 using copper-64 labeled peptide antagonist.

@ast

PET imaging of CXCR4 using copper-64 labeled peptide antagonist.

@en

PET imaging of CXCR4 using copper-64 labeled peptide antagonist.

@nl

type

label

PET imaging of CXCR4 using copper-64 labeled peptide antagonist.

@ast

PET imaging of CXCR4 using copper-64 labeled peptide antagonist.

@en

PET imaging of CXCR4 using copper-64 labeled peptide antagonist.

@nl

prefLabel

PET imaging of CXCR4 using copper-64 labeled peptide antagonist.

@ast

PET imaging of CXCR4 using copper-64 labeled peptide antagonist.

@en

PET imaging of CXCR4 using copper-64 labeled peptide antagonist.

@nl

P1433

Q34895626-71FAE619-7FD8-4E0C-91B7-0203435561C1

P1476

Q34895626-6A8E2C96-0284-457E-9C7A-A62C7E27D87B

P2093

Q34895626-7402F406-E2A2-4426-AC60-7BE6B1873030

Q34895626-84694895-E126-4527-BF0E-2DF655403236

Q34895626-C10A83FA-AD49-4400-8103-4397F6061E3B

Q34895626-F15ECC24-D2C4-4622-A33A-8AB2CC89726E

P2860

Q34895626-00F8466D-C35A-447E-B4AE-BE89A1DCB02C

Q34895626-00FA3FBE-74DF-49FA-9617-C7430950B371

Q34895626-228B081D-1DE2-4705-A547-81F1AA01400F

Q34895626-264FDFC1-675C-4A29-9DF1-D677C7D0087E

Q34895626-29F0E076-76BB-409F-9997-3440C345F216

Q34895626-366A05E5-222C-4DEA-999F-B570AAD26B53

Q34895626-41694CDC-7303-4AC1-A474-21FE15E2DA27

Q34895626-418681D3-2EEA-49A3-90E7-DC5CACDD6B72

Q34895626-44839610-DAB2-4994-8512-9355DD571423

Q34895626-48562E39-059A-4EE6-943B-8439C80B1712

P304

Q34895626-F30E9E4F-CA5B-47E0-AB2B-0E8D5FAF833D

P31

Q34895626-96C364B6-D827-43BC-8C8D-E1589BA5C11E

P356

Q34895626-9E3F1867-CBB7-43B1-B639-6D8D825C4C8F

P478

Q34895626-A83571CE-50C0-4E7E-9E1D-A20A01C8EF59

P50

Q34895626-133A70F9-F82B-45F6-BAB7-53FEC45EBAB1

Q34895626-14BD1F56-5431-4555-A1DD-60F65CD950DD

Q34895626-7C721E17-B41F-48D7-ABE3-9B468162536D

Q34895626-7D0313F4-78BB-46DD-A163-59BAB47AFE66

P577

Q34895626-C94DE117-FE1E-41EF-AA34-7ECD7D1B928F

P698

Q34895626-BE40B555-CCCB-47C3-9800-EC5DB17A4913

P932

Q34895626-C7153711-09C9-4587-AD64-8CB9F1D01038

P356

P1433

P1476

PET imaging of CXCR4 using copper-64 labeled peptide antagonist.

@en

P2093

Ido D Weiss

http://www.w3.org/2001/XMLSchema#string

Joshua M Farber

http://www.w3.org/2001/XMLSchema#string

Lawrence P Szajek

http://www.w3.org/2001/XMLSchema#string

Ying Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of chemokine receptors in breast cancer metastasis

Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen

Inducible short-term and stable long-term cell culture systems reveal that the PAX3-FKHR fusion oncoprotein regulates CXCR4, PAX3, and PAX7 expression

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes.

Molecular imaging of CXCR4 receptor expression in human cancer xenografts with [64Cu]AMD3100 positron emission tomography

Chemokines in cancer.

Contribution of Duffy antigen to chemokine function.

Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT

Immune and nervous system CXCL12 and CXCR4: parallel roles in patterning and plasticity.

P304

251-262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/THNO/V01P0251

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Dale O Kiesewetter

P577

2011-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21544263

http://www.w3.org/2001/XMLSchema#string

P932

3085282

http://www.w3.org/2001/XMLSchema#string